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Abstract
Background: Complications from premature birth contribute to 35 % of neonatal deaths globally; therefore, efforts
to improve clinical outcomes of preterm (PT) infants are imperative. Bubble continuous positive airway pressure
(bCPAP) is a low-cost, effective way to improve the respiratory status of preterm and very low birth weight (VLBW)
infants. However, bCPAP remains largely inaccessible in resource-limited settings, and information on the scale-up
of this technology in rural health facilities is limited. This paper describes health providers’ adherence to bCPAP
protocols for PT/VLBW infants and clinical outcomes in rural Rwanda.
Methods: This retrospective chart review included all newborns admitted to neonatal units in three rural hospitals in
Rwanda between February 1st and October 31st, 2013. Analysis was restricted to PT/VLBW infants. bCPAP eligibility,
identification of bCPAP eligibility and complications were assessed. Final outcome was assessed overall and by bCPAP
initiation status.
Results: There were 136 PT/VLBW infants. For the 135 whose bCPAP eligibility could be determined, 83 (61.5 %) were
bCPAP-eligible. Of bCPAP-eligible infants, 49 (59.0 %) were correctly identified by health providers and 43 (51.8 %) were
correctly initiated on bCPAP. For the 52 infants who were not bCPAP-eligible, 45 (86.5 %) were correctly identified as not
bCPAP-eligible, and 46 (88.5 %) did not receive bCPAP. Overall, 90 (66.2 %) infants survived to discharge, 35 (25.7 %) died,
3 (2.2 %) were referred for tertiary care and 8 (5.9 %) had unknown outcomes. Among the bCPAP eligible infants, the
survival rates were 41.8 % (18 of 43) for those in whom the procedure was initiated and 56.5 % (13 of 23) for those in
whom it was not initiated. No complications of bCPAP were reported.
Conclusion: While the use of bCPAP in this rural setting appears feasible, correct identification of eligible newborns was
a challenge. Mentorship and refresher trainings may improve guideline adherence, particularly given high rates of staff
turnover. Future research should explore implementation challenges and assess the impact of bCPAP on long-term
outcomes.
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Background
Over 2.9 million neonatal deaths occur every year, repre-
senting 44 % of all under five deaths [1–3]. In Rwanda,
despite a rapid decline in under-five mortality, the number
of deaths in the neonatal period remains high (27/1000
live births) with little change over the past 10 years [4, 5].
Major causes of neonatal deaths include preterm birth,
birth asphyxia and infections. Recently, complications re-
lated to prematurity have surpassed pneumonia and diar-
rheal diseases as the number one cause death in children,
and account for 35 % of all neonatal deaths [1–3, 6–8].
Hospital-based interventions targeting these causes are
needed to reduce neonatal mortality, particularly in low
and middle income countries [9–11].
The implementation of hospital-based interventions is
challenging in resource limited settings. Specifically, in-
tensive care unit technology for respiratory distress, such
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as a mechanical ventilation, is often not available due to
high costs, maintenance demands and the need for highly
trained staff. However, continuous positive airway pressure
(CPAP) has been demonstrated to be a simple, low-cost
and effective alternative to improve the respiratory status of
preterm infants with respiratory distress syndrome [12, 13],
and decrease the need for conventional mechanical ventila-
tors [12, 14]. CPAP helps keep the respiratory tract and
lungs open, promotes comfortable breathing, improves
oxygen levels and decreases apnea in premature infants.
Bubble CPAP (bCPAP) is the least expensive and least
complicated CPAP option, making this the preferred tech-
nology in resource-limited settings [15, 16].
To date, few studies have been conducted to show the
impact and feasibility of bCPAP in areas with limited re-
sources. These studies, most of which were conducted in
teaching and/or urban hospitals, have shown that bCPAP
can reduce the need for mechanical ventilation and can be
applied by nurses after a short on-the-job training on the
protocol and equipment [12, 17]. However, little research
has been done on the use of bCPAP in rural resource-
limited settings and hospitals without pediatric specialists.
In January 2013, the Rwandan Ministry of Health
(MOH), in collaboration with Partners In Health (PIH),
introduced a bCPAP program integrated into broader
neonatal care services for newborns with respiratory dis-
tress in three rural district hospitals (Butaro, Kirehe and
Rwinkwavu District Hospitals). Nurses and general practi-
tioners working in the neonatal units in these hospitals
with a background in neonatal care services received in-
tensive training on advanced neonatal care, focusing on
the bCPAP protocol, safe assembly, maintenance and
trouble-shooting of different issues related to bCPAP use.
The training was supplemented by ongoing clinical men-
torship and intermittent refresher trainings led by PIH
and local MOH bCPAP champions.
The objectives of this study are to describe the pro-
vider adherence to bCPAP protocol for preterm and very
low birth weight (PT/VLBW) infants and to describe the
outcomes of these infants at the three district hospitals.
The ultimate goal is to better understand the use of
bCPAP in rural resource-limited settings in order to im-
prove the quality of bCPAP implementation and inform
the scale-up of this technology in similar settings.
Methods
This retrospective cohort study included infants receiving
care at neonatal units at Rwinkwavu, Kirehe and Butaro
District Hospitals from February 1, 2013 to October 31,
2013. The catchment area included 865,000 people and
care at the hospital was obtained after referral from one of
the 41 health centers within the districts. These three hos-
pitals were selected for the study as they were the only
rural district hospitals providing basic neonatal care using
bCPAP in Rwanda in 2013. A team of nurses and general
practitioners worked permanently in these units providing
care to an average of 25 infants every month in each hos-
pital. Infants who needed intensive neonatal care, includ-
ing mechanical ventilators, were referred to tertiary
hospitals in Kigali city (the capital of Rwanda). Following
the training on implementation of bCPAP, Rwinkwavu
and Kirehe District Hospitals benefited from fairly consist-
ent mentorship from PIH pediatric specialists during the
study period while Butaro hospital had more intermittent
specialist presence.
Respiratory assessment to determine the need for
bCPAP is based on physical examination (such as grunt-
ing, nasal flaring and chest retraction) and vital signs
(including respiratory rate and/or oxygen saturation). In
addition, the etiology of respiratory symptoms and the
natural history of that diagnosis are considered. Once
the overall assessment is complete, the degree of respira-
tory distress is categorized as mild, moderate or severe.
Moderate to severe signs include moderate to severe
grunting, flaring, retractions and respiratory rate >70
or <30 and/or oxygen saturation <90 % (The oxygen
saturation was measured using pulse oximeter). Based
on the bCPAP protocol used in the three district hospi-
tals, any newborn with a moderate to severe respiratory
distress should have been initiated on bCPAP (Fig. 1).
Furthermore, preterm (gestational age (GA) <33 weeks)
or very low birth weight (<1500 g) infants with any de-
gree of respiratory distress (mild, moderate or severe)
should have been initiated on bCPAP. Preterm infants
with significant apnea and bradycardia of prematurity
were also eligible.
Our study population included all PT/VLBW infants ad-
mitted in neonatology units at the three hospitals. All
term and near term infants (GA ≥33 weeks and/or birth
weight ≥1500 g) were excluded as the severity of their re-
spiratory distress was not captured in the patient charts
and therefore eligibility for bCPAP could not be ascer-
tained. For infants included in the study, we added a cat-
egory of unknown to indicate missing data. The following
information was extracted from the patient charts and
registers in the neonatology and maternity unit: place of
birth, birth weight, gestational age, respiratory rate, oxy-
gen saturation, presence of physical signs of respiratory
distress (grunting, chest retraction, nasal flaring), bCPAP
recommendation and initiation, final disposition (recov-
ered, referred or died) and presence of bCPAP complica-
tions (skin injury, pneumothorax, abdominal distention).
We categorized PT/VLBW infants with at least one sign of
respiratory distress as bCPAP eligible and those without
any sign of respiratory distress as bCPAP ineligible. Data
was extracted into a standard data collection form, and a
file linking the study ID to the mother and neonate ID was
kept separately during the data collection and destroyed
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after data validation. We analyzed data using Stata 12.1
(College Station, TX: StataCorp LP). We used descriptive
statistics reporting number and percent of infant charac-
teristics, infants identified as eligible for bCPAP, infants for
whom bCPAP was initiated and clinical outcomes based
on CPAP eligibility. We also used median and interquartile
range for the duration of stay in the hospital.
The study received technical and ethical approvals
from Rwanda institutional review boards: The Inshuti
Mu Buzima Research Committee (IMBRC), the National
Health Research Committee (NHRC) and the Rwanda Na-
tional Ethics Committee (RNEC). As the study used de-
identified routinely corrected data, the consent for parents
was waived. STROBE (STrengthening the Reporting of OB-
servational studies in Epidemiology) guidelines were also
followed for this study.
Results
During the study period, 862 infants were admitted in the
three hospitals. Of these, 136 (16 %) were identified as PT/
VLBW and included in the analysis (Table 1). Of the 136
infants, 75.7 % (n = 103) were VLBW and 57.4 % (n = 78)
were preterm. Most of the PT/VLBW infants (n = 117,
86 %) were born at a health facility, either hospital or
health center. The median number of days of stay at the
hospital was 19 with an interquartile range of 6–32 days.
In assessing the presence of respiratory distress symptoms
among PT/VLBW infants, 61.0 % (n = 83) showed at least
one sign of respiratory distress (Table 2). Many of the
infants (50.7 %, n = 69) had low oxygen saturation
(SpO2 <90 %) and 38 infants (28.4 %) had chest retraction.
In some cases, the clinicians only mentioned infants in re-
spiratory distress without specifying the physical symp-
toms. One infant did not have documentation of the
presence or absence of respiratory distress and thus,
bCPAP eligibility could not be determined.
Of the 135 PT/VLBW infants whose bCPAP eligibility
could be determined, 61.5 % (n = 83) were bCPAP-eligible
of which 59.0 % (n = 49) were correctly identified by
health providers and for 51.8 % (n = 43) bCPAP was initi-
ated. Twenty-three bCPAP-eligible infants (27.7 %) had no
indication of being identified as bCPAP eligible or of being
initiated on bCPAP. Information around identification
was missing for 13.3 % (n = 11) of infants who were
eligible (Table 3). For the 52 infants who were not
bCPAP-eligible, 45 (86.5 %) were correctly identified
as not bCPAP-eligible and 46 (88.5 %) did not receive
bCPAP.
Overall, among the 136 PT/VLBW admitted, 90 (66.2 %)
infants survived to discharge, 35 (25.7 %) died and 3
(2.2 %) were referred for tertiary care. Outcome informa-
tion was missing for 8 (5.9 %) infants. For the 43 infants
who were bCPAP-eligible and for whom bCPAP was initi-
ated, 41.9 % (n = 18) recovered and 48.8 % (n = 21) died
Fig. 1 CPAP indication and implementation for newborns with respiratory distress based on the Rwanda CPAP protocol 2013
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(Table 4). Of the 23 bCPAP-eligible infants for whom
bCPAP was not initiated, 56.5 % (n = 13) recovered, 39.1 %
(n = 9) died and information about the outcome was miss-
ing for 4.4 % (n = 1). Outcome information was missing
for 1 (2.3 %) infant. A large proportion of infants who were
CPAP ineligible recovered whether bCPAP was initiated
(100 %, 2 out 2) or not initiated (93.5 %, 43 out of 46). For
infants who did receive bCPAP, no complications such as
skin injury, pneumothorax or abdominal distention were
reported.
Discussion
In this study, we assessed the implementation of
bCPAP with PT/VLBW infants at three district hospi-
tals in rural Rwanda and found the intervention feasible
in a resource-limited rural setting. Over the nine-month
period, 45 infants were initiated on bCPAP, demonstrating
that bCPAP – an evidence-based intervention to improve
survival or PT/VLBW infants – is filling a medical care
need for neonates. However, only 52 % of bCPAP-eligible
infants received bCPAP, suggesting ongoing gaps in cor-
rect identification and initiation of eligible infants. We
suspect that this low sensitivity might be a result of
turnover of nurses and doctors and could be improved
with increased onsite mentorship and refresher trainings,
particularly to identify early and mild signs of distress
promptly for immediate CPAP initiation to gain the full
benefit of the intervention. Qualitative research to assess
and understand the barriers to implementation experi-
enced by nurses and doctors is also advised.
Conversely, 88.5 % of bCPAP ineligible infants were not
initiated, indicating that clinicians are not exposing
Table 1 Characteristics of infants admitted to the neonatology unit in three district hospitals in Rwanda
Population characteristics Preterm or very low birth weight infants Term and near term infants who are not very low birth weight
N = 136 N = 726
n % n %
Place of birth
Hospital 66 48.5 419 57.7
Health center 51 37.5 255 35.1
Home 14 10.3 32 4.4
Unknown 5 3.7 20 2.8
Birth weight
Very low birth weight (<1500 g) 103 75.7
Low birth weight (1500–2499 g) 31 22.8 224 30.9
Normal birth weight (>=2500 g) 2 1.5 437 60.1
Unknown 0 0 65 9.0
Gestation age at birth
<33 weeks 78 57.4
33–36 weeks 19 14.0 71 9.8
=37 weeks 9 6.6 548 75.5
Unknown 30 22.1 107 14.7
Duration of stay in the hospital N = 128 N = 705
Median (IQR) 19 (6–32) 7 (3–10)
0–7 days 34 25.0 413 56.9
8–14 days 18 13.2 140 19.3
15–30 days 34 25.0 52 7.2
>30 days 29 21.3 33 4.5
Unknown 21 15.4 88 12.1
Table 2 Evidence of respiratory distress among preterm
(<33 weeks) or very low birth weight (<1500 g) infants
Sign of respiratory distress (N = 136) Infants with symptoms
n %
SpO2 <90 % 69 50.7
Grunting (N = 134) 17 12.7
Chest retraction (N = 134) 38 28.4
Nasal flaring (N = 134) 15 11.2
Respiration rate <30 or >70 24 17.7
At least one sign of respiratory distress
(N = 135)
83 61.5
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ineligible infants to possible bCPAP side effects and con-
serving the machines for the infants most in need. Only
two of the bCPAP initiated infants were bCPAP ineligible
according to medical file documentation, an improvement
over a study in Malawi where of the 11 neonates treated
with bCPAP, six did not meet initiation criteria [16].
A quarter of infants included in this study died before
discharge from the hospital. This mortality rate is similar
to outcomes of PT/VLBW infants in similar settings in
sub-Saharan Africa [18–20]. The highest rate of death in
this study, nearly 49 %, occurred in infants eligible for
CPAP who died after initiation. Given the low sensitivity of
CPAP initiation, we suspect that this group had a higher
severity of respiratory distress and other comorbidities
compared to infants who were not initiated on CPAP. We
were unable to accurately assess the severity of respiratory
distress among those who were eligible but not initiated on
CPAP; however, we suspect that they were likely to be less
severely ill. In addition, our study was conducted in rural
hospitals without full-time pediatric specialists on staff;
however, similarly high mortality rates among bCPAP initi-
ated infants have been reported in studies conducted in
teaching hospitals with more specialized staff [15–17, 21].
There are several limitations to consider for this study.
This study is based entirely on routinely collected data
available in the patient file. While we cannot verify the ac-
curacy of diagnosis, we believe the information provided
by clinicians is reliable because of their clinical back-
ground and expertise. For some cases, however, there was
limited documentation from clinicians especially on the
severity of respiratory distress. Our study excluded term
and near-term infants whose bCPAP eligibility depended
on the severity of respiratory distress, which was difficult
to capture in patients records. Furthermore, we were un-
able to assess the degree of distress among eligible infants
whom were not provided bCPAP to assess for possible
selection bias. In a few cases for the PT/VLBW infants, it
was difficult to determine whether the infant was identified
for bCPAP or initiated on bCPAP. To improve documen-
tation and resulting quality improvement, we recommend
the revision of the neonatology patient chart and onsite
training/supervision. Despite these challenges, we believe
these results are informative as they represent the first as-
sessment of bCPAP implementation in rural Rwanda and
thus provide a basis for informing better service delivery
and bCPAP scale-up in similar settings.
Table 3 bCPAP identification and initiation for preterm (<33 weeks) or very low birth weight (<1500) infants
bCPAP eligible bCPAP Not eligible Total
N = 83 N = 52 N = 135a
n % n % n %
Identified as bCPAP-Eligible
Yes 49 59.0 3 5.8 52 38.5
No 23 27.7 45 86.5 68 50.4
Unknown 11 13.3 4 7.7 15 11.1
bCPAP Initiated
Yes 43 51.8 2 3.9 36 33.3
No 23 27.7 46 88.5 60 51.3
Unknown 17 20.5 4 7.7 21 17.9
aOne infant’s eligibility could not be determined
Table 4 Clinical Outcomes for Preterm (<33 weeks) or very low birth weight infants (<1500 g) with and without bCPAP intervention
Recovered/ Discharged Died Transferred for care Outcome unknown
N = 89 N = 35 N = 3 N = 8
n % n % n % n %
Eligible
bCPAP Initiated (N = 43) 18 41.8 21 48.8 3 6.9 1 2.3
bCPAP Not Initiated (N = 23) 13 56.5 9 39.1 0 0 1 4.4
bCPAP Initiation Unknown (N = 17) 10 58.8 4 23.5 0 0 3 17.7
Not eligible
bCPAP Initiated (N = 2) 2 100 0 0 0 0 0 0
bCPAP Not Initiated (N = 46) 43 93.5 0 0 0 0 3 6.5
bCPAP Initiation Unknown (N=4) 3 75.0 1 25.0 0 0 0 0
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Conclusion
To our knowledge, this is the first study of implementation
of bCPAP in rural district hospitals in sub-Saharan Africa.
We found that bCPAP is a feasible way to support infants
with respiratory distress in resource-limited settings. While
the introduction and use of bCPAP in this setting appears
promising, there remain challenges in terms of guideline
adherence. We believe that providing more intense men-
torship and refresher trainings can improve guideline ad-
herence, particularly given the high rates of staff turnover.
We also recommend the adaption of clinical charts to
facilitate clinical determination of degree of respiratory dis-
tress and consequent decision-making. Future qualitative
and prospective research is needed to determine challenges
encountered by clinicians in using bCPAP as well as delin-
eate the reasons for high mortality among infants put on
CPAP. Finally and critically, more research is needed to
assess the impact of bCPAP on long-term survival and out-
comes for PT/VLBW infants.
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